Step by Stepa HemeOncBuddy patient portal

R-DHAP

Illustration: R-DHAP

Say it: R-D-hap

Rituximab, dexamethasone, cytarabine and cisplatin

R-DHAP is a strong four medicine plan used mostly for lymphoma that has come back, to shrink it before a stem cell transplant.

Also called: RDHAP, DHAP, R-DHAP salvage, R-DHAX (with oxaliplatin), R-DHAOx, DHAP for Hodgkin lymphoma

What it is

When lymphoma returns after the first treatment, a different set of medicines is used to get it under control again (sometimes called salvage treatment). If it works, many people then have high dose chemotherapy with their own stem cells (autologous transplant), which gives the best chance of long term control or cure. In mantle cell lymphoma, R-DHAP is part of the first treatment for some younger patients.

Rrituximab
Ddexamethasone
HAhigh dose Ara-C (cytarabine)
PPlatinol (cisplatin)

Often used for

DHAP without rituximab
Used for Hodgkin lymphoma and for lymphomas that do not carry the CD20 marker.
R-DHAX or R-DHAOx
Oxaliplatin is used instead of cisplatin, which can be easier on the kidneys and hearing.

The medicines in this plan

Rituximab
An antibody that targets CD20, a marker on B-cell lymphoma cells. Given through a vein on day 1.
Dexamethasone
A steroid that kills lymphoma cells. Given as a pill or IV on days 1 to 4.
Cytarabine (Ara-C)
High dose chemotherapy given through a vein as 2 doses, 12 hours apart, on day 2.
Cisplatin
Platinum chemotherapy given through a vein on day 1, often slowly over many hours, with lots of IV fluid to protect the kidneys.

How you get it

R-DHAP is often given in the hospital over 2 to 4 days, though some centers give it as an outpatient with very close follow up. Each cycle is 21 days, and most people get 2 to 3 cycles before stem cell collection and transplant. You will get a white blood cell booster shot after each cycle. Your schedule may be different.

A typical cycle

Day 1
Rituximab, then cisplatin with lots of IV fluid. Dexamethasone starts.
Day 2
Cytarabine through a vein, 2 doses 12 hours apart. Steroid eye drops start.
Days 3 to 4
Dexamethasone continues. Many people go home on day 3 or 4.
Days 5 to 21
Booster shot, then recovery. Blood counts are lowest around days 10 to 14, and transfusions may be needed.
After 2 to 3 cycles
A PET scan to check response, then stem cell collection and transplant if planned.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Lymphoma

Sources

Quick answers

What is R-DHAP?
R-DHAP is a strong four medicine plan used mostly for lymphoma that has come back, to shrink it before a stem cell transplant. Rituximab, dexamethasone, cytarabine and cisplatin.
What does R-DHAP stand for?
R = rituximab; D = dexamethasone; HA = high dose Ara-C (cytarabine); P = Platinol (cisplatin).
How is R-DHAP given?
R-DHAP is often given in the hospital over 2 to 4 days, though some centers give it as an outpatient with very close follow up. Each cycle is 21 days, and most people get 2 to 3 cycles before stem cell collection and transplant. You will get a white blood cell booster shot after each cycle. Your schedule may be different.
What are the common side effects of R-DHAP?
Nausea and vomiting, which can be strong with cisplatin. Low blood counts with high infection risk, and possible need for blood or platelet transfusions. Tiredness. Ringing in the ears or trouble hearing. Kidney strain and low magnesium or potassium. Red, sore eyes from cytarabine. Chills or fever during the first rituximab infusion. Tingling in fingers and toes, high blood sugar and trouble sleeping.
When should I call my care team during R-DHAP?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; Vomiting that keeps you from drinking or taking medicines; Passing much less urine than usual, or dizziness when standing; Bleeding that will not stop, or many new bruises; Trouble walking, poor balance or slurred speech; Sudden hearing loss, or new loud ringing in the ears; Shortness of breath or chest pain.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.